DIVE Medical, a company focused on making visual function exploration accessible even for non-verbal patients, has secured $1.3M in a Series A funding round. The capital infusion marks a significant step for the firm, which specializes in providing automatic, fast, and accurate assessments of visual function.
Its technology is particularly vital for individuals who cannot articulate their symptoms, such as young children or those with certain neurological conditions. By automating the process, DIVE Medical aims to deliver precise diagnostic insights where traditional methods often fall short, ensuring more inclusive and effective eye care.
